These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 19237696)
1. No shortcuts to outcome in MS clinical trials? Koch-Henriksen N Neurology; 2009 Feb; 72(8):686-7. PubMed ID: 19237696 [No Abstract] [Full Text] [Related]
2. MRI as an outcome in multiple sclerosis clinical trials. Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945 [TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis. Boggild M; Ford H Clin Evid; 2002 Jun; (7):1195-207. PubMed ID: 12230737 [No Abstract] [Full Text] [Related]
4. [Beta-interferon clinical trials using MRI in patients with multiple sclerosis]. Lebrun C Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):761-7. PubMed ID: 11677396 [TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis. Hawker K; Frohman E Prim Care; 2004 Mar; 31(1):201-26. PubMed ID: 15110166 [No Abstract] [Full Text] [Related]
6. [Treatment of progressive forms of multiple sclerosis]. Edan G Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1008-13. PubMed ID: 11787331 [TBL] [Abstract][Full Text] [Related]
7. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis. Zhao Y; Traboulsee A; Petkau AJ; Li D Neurology; 2008 Mar; 70(13 Pt 2):1092-7. PubMed ID: 18003938 [TBL] [Abstract][Full Text] [Related]
8. A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing-remitting or secondary progressive multiple sclerosis. Vollmer TL; Wynn DR; Alam MS; Valdes J Mult Scler; 2011 Feb; 17(2):181-91. PubMed ID: 21135022 [TBL] [Abstract][Full Text] [Related]
13. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Sormani MP; Rovaris M; Comi G; Filippi M Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of multiple sclerosis]. Simó M Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815 [TBL] [Abstract][Full Text] [Related]
15. [Multiple sclerosis: between wish and reality]. Kümpfel T; Hohlfeld R MMW Fortschr Med; 2005 May; 147 Spec No 2():83-5. PubMed ID: 15968879 [TBL] [Abstract][Full Text] [Related]